News

The patent application includes 30 claims covering composition of matter and formulations of MC3, as well as methods of using these compositions and formulations. This second generation LNP

Pharmacy Xpert, which is a part of the Clinical Xpert Suite of workflow solutions, is a clinical intelligence dashboard that aids hospital pharmacists in eliminating medication errors and

The transaction is subject to normal post-closing adjustments. BioReliance will become part of SAFC, the custom manufacturing and services business unit of Sigma-Aldrich. The acquisition is expected to

The company has reported a net loss of $12.75m, or $0.17 per share, for the second quarter of fiscal year 2012, compared to net loss of $14.23m, or

These methods are broadly utilized as a part of Precision’s DNE genome engineering technology, the company said. Precision announced in October 2011 that it has asserted the ‘867

The IDMC reviewed all available study data and determined that the trial should continue as designed and conducted, which is the third such review and recommendation by the

The neglected tropical diseases include Chagas disease, helminth infections, leishmaniasis and sleeping sickness. Under the collaboration, DNDi and Abbott scientists will focus initial efforts on discovering and advancing

The VANISH-2 has evaluated the safety and efficacy of Varisolve in patients with symptomatic and visible varicose veins and saphenofemoral junction incompetence. The study met all primary, secondary

AMT has developed Glybera as a treatment for patients with the genetic disorder lipoprotein lipase deficiency (LPLD). On 23 October 2011, AMT received a non-approvable opinion from the